Article
Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2010
Eussen Simone J P M, Vollset Stein Emil, Hustad Steinar, Midttun Øivind, Meyer Klaus, Fredriksen Ase, Ueland Per Magne, Jenab Mazda, Slimani Nadia, Boffetta Paolo, Overvad Kim, Thorlacius-Ussing Ole, Tjønneland Anne, Olsen Anja, Clavel-Chapelon Françoise, Boutron-Ruault Marie-Christine, Morois Sophie, Weikert Cornelia, Pischon Tobias, Linseisen Jakob, Kaaks Rudolf, Trichopoulou Antonia, Zilis Demosthenes, Katsoulis Michael, Palli Domenico, Pala Valeria, Vineis Paolo, Tumino Rosario, Panico Salvatore, Peeters Petra H M, Bueno-de-Mesquita H Bas, van Duijnhoven Fränzel J B, Skeie Guri, Muñoz Xavier, Martínez Carmen, Dorronsoro Miren, Ardanaz Eva, Navarro Carmen, Rodríguez Laudina, VanGuelpen Bethany, Palmqvist Richard, Manjer Jonas, Ericson Ulrika, Bingham Sheila, Khaw Kay-Tee, Norat Teresa, Riboli Elio
Abstract excerpt
BACKGROUND: B-vitamins are essential for one-carbon metabolism and have been linked to colorectal cancer. Although associations with folate have frequently been studied, studies on other plasma vitamins B2, B6, and B12 and colorectal cancer are scarce or inconclusive. METHODS: We carried out a nested case-control study within the European Prospective Investigation into Cancer and Nutrition, including 1,365...
Read the complete abstract on PubMed